Commonwealth Equity Services
MRNA icon

Commonwealth Equity Services’s Moderna MRNA Stock Holding History

Commonwealth Equity Services’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.66M Buy
66,546
+18,006
+37% +$932K 0.01% 1454
2026
Q1 		$2.47M Buy
48,540
+4,916
+11% +$229K ﹤0.01% 1829
2025
Q4 		$1.29M Sell
43,624
-11,783
-21% -$320K ﹤0.01% 2372
2025
Q3 		$1.43M Sell
55,407
-22,098
-29% -$616K ﹤0.01% 2295
2025
Q2 		$2.14M Sell
77,505
-11,753
-13% -$310K ﹤0.01% 1929
2025
Q1 		$2.53M Buy
89,258
+14,738
+20% +$523K ﹤0.01% 1749
2024
Q4 		$3.1M Buy
74,520
+345
+0.5% +$16.5K ﹤0.01% 1562
2024
Q3 		$4.96M Sell
74,175
-2,401
-3% -$220K 0.01% 1231
2024
Q2 		$9.09M Buy
76,576
+1,392
+2% +$176K 0.01% 847
2024
Q1 		$8.01M Buy
75,184
+411
+0.5% +$41.4K 0.01% 901
2023
Q4 		$7.44M Sell
74,773
-8,029
-10% -$675K 0.01% 880
2023
Q3 		$8.55M Sell
82,802
-2,402
-3% -$268K 0.02% 756
2023
Q2 		$10.4M Sell
85,204
-4,439
-5% -$592K 0.02% 667
2023
Q1 		$13.8M Buy
89,643
+3,224
+4% +$532K 0.03% 538
2022
Q4 		$15.5M Sell
86,419
-2,670
-3% -$437K 0.04% 457
2022
Q3 		$10.5M Sell
89,089
-11,096
-11% -$1.68M 0.03% 554
2022
Q2 		$14.3M Buy
100,185
+9,742
+11% +$1.39M 0.04% 440
2022
Q1 		$15.6M Sell
90,443
-8,612
-9% -$1.45M 0.04% 450
2021
Q4 		$25.2M Sell
99,055
-5,063
-5% -$1.48M 0.06% 310
2021
Q3 		$40.1M Buy
104,118
+3,677
+4% +$1.36M 0.1% 197
2021
Q2 		$23.6M Sell
100,441
-4,930
-5% -$881K 0.06% 305
2021
Q1 		$13.8M Buy
105,371
+474
+0.5% +$68.7K 0.04% 420
2020
Q4 		$11M Buy
104,897
+11,992
+13% +$1.21M 0.03% 450
2020
Q3 		$6.57M Buy
92,905
+13,522
+17% +$943K 0.02% 563
2020
Q2 		$5.1M Buy
79,383
+33,650
+74% +$1.84M 0.02% 604
2020
Q1 		$1.37M Buy
45,733
+29,102
+175% +$670K 0.01% 1098
2019
Q4 		$325K Buy
16,631
+2,102
+14% +$37.3K ﹤0.01% 2247
2019
Q3 		$231K Sell
14,529
-842
-5% -$12.4K ﹤0.01% 2456
2019
Q2 		$225K Buy
+15,371
New +$330K ﹤0.01% 2432

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Commonwealth Equity Services's MRNA Position: Q2 2026 in Review

Commonwealth Equity Services increased its Moderna (MRNA) stake by 37% in Q2 2026, buying an estimated $932K and bringing the position to 66,546 shares worth $4.66M. The position accounts for 0.01% of the portfolio, ranked #1454.

Commonwealth Equity Services first reported a position in MRNA in Q2 2019 and has held it in 29 quarters since. The position peaked at $40.1M in Q3 2021. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Commonwealth Equity Services held 66,546 shares of Moderna worth $4.66M as of Q2 2026.
  • Commonwealth Equity Services bought 18,006 Moderna shares in Q2 2026, an estimated $932K.
  • Moderna made up 0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #1454 holding.
  • Commonwealth Equity Services first reported a position in Moderna in Q2 2019 and has held it in 29 quarters since.
  • Commonwealth Equity Services's Moderna position peaked at $40.1M in Q3 2021.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.